263 related articles for article (PubMed ID: 26912148)
1. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
Stupfler B; Birck C; Séraphin B; Mauxion F
Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148
[TBL] [Abstract][Full Text] [Related]
2. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
3. Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking.
Ameerul A; Almasmoum H; Pavanello L; Dominguez C; Winkler GS
J Mol Biol; 2022 Jul; 434(14):167662. PubMed ID: 35640718
[TBL] [Abstract][Full Text] [Related]
4. Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation.
Ruan L; Osawa M; Hosoda N; Imai S; Machiyama A; Katada T; Hoshino S; Shimada I
J Biol Chem; 2010 Sep; 285(36):27624-31. PubMed ID: 20595394
[TBL] [Abstract][Full Text] [Related]
5. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.
Ezzeddine N; Chang TC; Zhu W; Yamashita A; Chen CY; Zhong Z; Yamashita Y; Zheng D; Shyu AB
Mol Cell Biol; 2007 Nov; 27(22):7791-801. PubMed ID: 17785442
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity.
Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z
Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182
[TBL] [Abstract][Full Text] [Related]
8. The BTG2 protein is a general activator of mRNA deadenylation.
Mauxion F; Faux C; Séraphin B
EMBO J; 2008 Apr; 27(7):1039-48. PubMed ID: 18337750
[TBL] [Abstract][Full Text] [Related]
9. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
Maryati M; Airhihen B; Winkler GS
Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases.
Funakoshi Y; Doi Y; Hosoda N; Uchida N; Osawa M; Shimada I; Tsujimoto M; Suzuki T; Katada T; Hoshino S
Genes Dev; 2007 Dec; 21(23):3135-48. PubMed ID: 18056425
[TBL] [Abstract][Full Text] [Related]
11. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.
Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L
J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase.
Hosoda N; Funakoshi Y; Hirasawa M; Yamagishi R; Asano Y; Miyagawa R; Ogami K; Tsujimoto M; Hoshino S
EMBO J; 2011 Apr; 30(7):1311-23. PubMed ID: 21336257
[TBL] [Abstract][Full Text] [Related]
13. mRNA Deadenylation Is Coupled to Translation Rates by the Differential Activities of Ccr4-Not Nucleases.
Webster MW; Chen YH; Stowell JAW; Alhusaini N; Sweet T; Graveley BR; Coller J; Passmore LA
Mol Cell; 2018 Jun; 70(6):1089-1100.e8. PubMed ID: 29932902
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
15. Biological role of the two overlapping poly(A)-binding protein interacting motifs 2 (PAM2) of eukaryotic releasing factor eRF3 in mRNA decay.
Osawa M; Hosoda N; Nakanishi T; Uchida N; Kimura T; Imai S; Machiyama A; Katada T; Hoshino S; Shimada I
RNA; 2012 Nov; 18(11):1957-67. PubMed ID: 23019593
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
[TBL] [Abstract][Full Text] [Related]
17. BTG/TOB factors impact deadenylases.
Mauxion F; Chen CY; Séraphin B; Shyu AB
Trends Biochem Sci; 2009 Dec; 34(12):640-7. PubMed ID: 19828319
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
Ogami K; Hosoda N; Funakoshi Y; Hoshino S
Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
[TBL] [Abstract][Full Text] [Related]
19. The central region of CNOT1 and CNOT9 stimulates deadenylation by the Ccr4-Not nuclease module.
Pavanello L; Hall B; Airhihen B; Winkler GS
Biochem J; 2018 Nov; 475(21):3437-3450. PubMed ID: 30309886
[TBL] [Abstract][Full Text] [Related]
20. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
